Northern Trust Company of Connecticut’s Bristol-Myers Squibb BMY Stock Holding History

Northern Trust Company of Connecticut's BMY Position: Q4 2013 in Review

Northern Trust Company of Connecticut increased its Bristol-Myers Squibb (BMY) stake by 18% in Q4 2013, buying an estimated $6.29M and bringing the position to 805,550 shares worth $42.8M. The position accounts for 0.27% of the portfolio, ranked #67.

Northern Trust Company of Connecticut first reported a position in BMY in Q2 2013 and has held it in 3 quarters since. 1,314 funds tracked by Wall St. Rank hold BMY as of Q4 2013.

• Northern Trust Company of Connecticut held 805,550 shares of Bristol-Myers Squibb worth $42.8M as of Q4 2013.
• Northern Trust Company of Connecticut bought 123,528 Bristol-Myers Squibb shares in Q4 2013, an estimated $6.29M.
• Bristol-Myers Squibb made up 0.27% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #67 holding.
• Northern Trust Company of Connecticut first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 3 quarters since.
• 1,314 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.